Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Plectasin NZ2114 – Novel Microbial Agent

Drug (Brand/Generic)

Plectasin variant NZ2114

Company/Licensee

Novozymes A/S/ Sanofi-Aventis

Therapy Class

Defensins

Product Description

Antibiotic

Current Indication

Treatment of gram-positive infections

Market Sector

Antiifectives

Development Status

Pre-clinical
Expand

Go Top